Overview: the epidemiology of neurodevelopmental disorders.
Yeargin-Allsopp
Marshalyn
M
The National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA. mxy1@cdc.gov
Boyle
Coleen
C
D001289:Attention Deficit Disorder with Hyperactivity / Q000453:epidemiology; D001321:Autistic Disorder / Q000453:epidemiology; D002493:Central Nervous System Diseases / Q000453:epidemiology*; D002547:Cerebral Palsy / Q000453:epidemiology / Q000209:etiology; D002648:Child; D015897:Comorbidity; D000013:Congenital Abnormalities / Q000453:epidemiology; D019049:Developed Countries; D003906:Developing Countries; D002658:Developmental Disabilities / Q000453:epidemiology*; D004781:Environmental Exposure / Q000009:adverse effects; D004827:Epilepsy / Q000453:epidemiology; D006801:Humans; D008607:Intellectual Disability / Q000145:classification / Q000453:epidemiology* / Q000209:etiology; D007854:Lead / Q000009:adverse effects; D008767:Methylmercury Compounds / Q000009:adverse effects; D015995:Prevalence; D012307:Risk Factors; D016135:Spinal Dysraphism / Q000453:epidemiology
D008767:Methylmercury Compounds; D007854:Lead